Africa: Advancing the Development of a Malaria Transmission-Blocking Vaccine

Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes to humans-a type of vaccine that researchers think could contribute to the eventual eradication of malaria. The partners-the PATH Malaria Vaccine Initiative (MVI), the National Institute of Allergy and Infectious Diseases (NIAID) and the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research (CIR)-are wor Source